Cite
HARVARD Citation
Sharma, K. et al. (2022). Prospective, randomised, parallel-group, open-label study to evaluate the effectiveness and safety of IMU-838, in combination with oseltamivir, in adults with COVID-19: the IONIC trial protocol. BMJ open. 12 (11), p. . [Online].